drugset / Trial / NCT02440009
A Randomized Trial of Itraconazole in Acute Stages of Allergic Bronchopulmonary Aspergillosis
Phase 2/3
Completed
191 enrolled
Post Graduate Institute of Medical Education and Research, Chandigarh
RandomizedSingle-groupOpen-labelTreatment
Summary
The study evaluates the addition of itraconazole to glucocorticoids in management of acute stages of allergic bronchopulmonary aspergillosis (ABPA). Half of the participants will receive glucocorticoids while the other half will receive itraconazole and glucocorticoids
Timeline
- Start
- 2014-05
- Primary completion
- 2017-07
- Completion
- 2017-07-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Itraconazole | Small molecule | 200 mg | Oral |
| Background | Prednisolone | Other / unclassified | 0.125 mg/kg | Oral |